G-FLOW

1. Air-Gapped Sovereign Hardware vs. Desktop Claude Plugins

In September 2026, Veeva announced its Study Builder Agent, aiming to configure Veeva EDC directly from study protocols in as little as 24 hours. However, Veeva’s delivery architecture introduces severe enterprise security hurdles: it is delivered as a Claude Cowork desktop plugin installed via a GitHub repository, requiring a separate AI subscription and routing proprietary clinical protocol parameters through third-party public AI APIs (Anthropic Claude).

For pharmaceutical sponsors and CROs, piping confidential, pre-publication Phase I–III oncology protocols through desktop AI plugins triggers immediate InfoSec, CISO, and legal compliance vetoes.

G-Flow runs 100% on-premise on dedicated physical hardware appliances. Deployed as dedicated Dell Blackwell enterprise nodes (Ocelot, Tiger, Jaguar, Cheetah tiers with up to 512GB Blackwell VRAM), G-Flow operates completely air-gapped behind your enterprise firewall. Not a single token or study parameter ever leaves your physical building. Zero cloud egress. Zero third-party LLM data exposure.

2. Universal Multi-EDC Agnosticism vs. Veeva Vault Lock-In

Veeva’s Study Builder Agent configures only Veeva EDC and Veeva DQS.

For mid-market and Tier-1 Contract Research Organizations (CROs), this single-ecosystem constraint is a commercial non-starter: over 60% of sponsor contracts mandate Medidata Rave or open CDISC architectures. Veeva cannot and will never compile production-ready Medidata Rave ALS spreadsheets or external CDISC packages for a competing EDC vendor.

G-Flow is universally vendor-agnostic. It parses the protocol once into an internal CDISC Intermediate Language (IL) and compiles directly into:

• Medidata Rave ALS (Architect Loader Sheets: Forms, Fields, Codelists, Unit Dictionaries, Edit Checks)
• Veeva Vault CDMS (Native Vault study blueprints and XML definitions)
• CDISC ODM-XML & SDM-XML (Standard-compliant operational data models)

One compiler handles all of your sponsors regardless of which EDC engine they mandate.

3. Raw Unstructured 150-Page PDFs vs. The USDM Prerequisite Trap

Veeva’s Study Builder Agent relies heavily on protocols already conforming to CDISC USDM (Unified Study Definitions Model) or clean digital inputs.

In clinical reality, 98% of clinical trial protocols in active development are messy, 150-page unstructured PDFs containing complex visual Schedule of Activities (SoA) tables, conditional footnote logic, and branching biomarker cohorts. Requiring a digitized USDM model merely pushes the manual transcription burden upstream onto the data management team.

G-Flow ingests unstructured PDFs natively. Using on-premise Vision-Language Models (SmolDocling), G-Flow parses multi-column visual SoA grids as spatial images, eliminating OCR line squishing. Every extracted variable is mathematically proven via Deterministic Character-Level Grounding, linking back to exact bounding-box coordinates (charInterval spans) on the source PDF page and verified by an on-premise Gemma 4 (31B) adversarial judge before database lock.

4. Production Silicon Today vs. Late 2026 Early Adopter Roadmap

Veeva announced its Study Builder Agent for early adopter availability in December 2026.

G-Flow is operational and benchmarked on live Dell Blackwell silicon today:

• NCT04586231 (120-page Phase III Renal Cell Carcinoma protocol): Fully compiled into production Medidata Rave ALS in 3 minutes 42 seconds.
• NCT01631552 (Phase III Breast Cancer protocol): Verified end-to-end 13-phase zero-mock compilation on physical GB10 Tiger hardware.

Architectural Comparison Matrix